Previous studies have shown a highly significant impact of MGMT status on the prognosis of patients with moderately vascularized tumors, but not in patients with highly vascularized tumors ( 17 , 23 ).
← all excerpts
Dynamic susceptibility contrast‑enhanced perfusion magnetic resonance imaging parameters for predicting <i>MGMT</i> promoter methylation and prognostic value in newly diagnosed patients with glioblastoma.
1
—
—